XTX Topco Ltd Invests $229,000 in Teleflex Incorporated (NYSE:TFX)

XTX Topco Ltd bought a new position in shares of Teleflex Incorporated (NYSE:TFX) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,087 shares of the medical technology company’s stock, valued at approximately $229,000.

A number of other hedge funds also recently modified their holdings of the stock. Seven Eight Capital LP acquired a new stake in shares of Teleflex during the 2nd quarter worth about $245,000. Hsbc Holdings PLC lifted its stake in shares of Teleflex by 4.9% during the 2nd quarter. Hsbc Holdings PLC now owns 127,077 shares of the medical technology company’s stock worth $26,684,000 after buying an additional 5,943 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Teleflex by 19.2% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 6,591 shares of the medical technology company’s stock worth $1,374,000 after buying an additional 1,063 shares during the last quarter. Argent Trust Co lifted its stake in shares of Teleflex by 11.4% during the 2nd quarter. Argent Trust Co now owns 1,000 shares of the medical technology company’s stock worth $210,000 after buying an additional 102 shares during the last quarter. Finally, Sofinnova Investments Inc. lifted its stake in shares of Teleflex by 12.4% during the 2nd quarter. Sofinnova Investments Inc. now owns 13,649 shares of the medical technology company’s stock worth $2,871,000 after buying an additional 1,507 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Truist Financial raised their price target on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research report on Monday, August 5th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Stephens raised their price target on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada raised their price target on shares of Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.57.

Teleflex Price Performance

TFX stock opened at $246.83 on Friday. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $257.85. The firm has a market cap of $11.63 billion, a P/E ratio of 39.62, a P/E/G ratio of 2.23 and a beta of 1.16. The company’s 50-day moving average price is $237.48 and its two-hundred day moving average price is $221.22.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, beating the consensus estimate of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The firm had revenue of $749.70 million for the quarter, compared to analyst estimates of $762.98 million. During the same period last year, the firm earned $3.41 EPS. The business’s quarterly revenue was up .9% compared to the same quarter last year. On average, analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Insider Activity at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the sale, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.43% of the stock is currently owned by insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.